AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases Large Population Screening Study Reached Key Milestone with Over 2,000 Confirmed Cases Philadelphia, PA, October 4, 2021 – AnPac Bio-Medical Science Co., Ltd. (Nasdaq:ANPC, “AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United […]

AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency PHILADELPHIA, September 30, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, announced today that it has received a written notification (the “Notification […]

AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists Philadelphia, Pennsylvania, August 30, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that its Philadelphia, PA Clinical Laboratory Improvement Amendments (“CLIA”) certified laboratory […]

AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO Philadelphia, Pennsylvania, August 17, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that it has hired Dr. Sunil Pandit, a successful life sciences veteran […]

AnPac Bio Announces Appointment of New Independent Director Independent Director has Strong Track Record at US Fortune 500 Companies Philadelphia, Pennsylvania, July 23, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that Mr. Chao Feng, […]